findmyKOL
Clinical trialNCT03021499CompletedPhase 3Interventional

Aurinia Renal Response in Active Lupus With Voclosporin

SponsorAurinia Pharmaceuticals Inc.Enrollment358Lupus Nephritis
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

185 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Argentina
  • Aurora Investigative Center

    Buenos Aires, Argentina

  • Aurora Investigative Center

    Caba, Argentina

  • Aurora Investigative Center

    Córdoba, Argentina

  • Aurora Investigative Center

    La Plata, Argentina

  • Aurora Investigative Center

    San Miguel de Tucumán, Argentina

Belarus
  • Aurora Investigative Cener

    Minsk, Belarus

  • Aurora Investigative Center

    Minsk, Belarus

  • Aurora Investigative Center

    Vitebsk, Belarus

Brazil
  • Aurora Investigative Center

    Curitiba, Brazil

  • Aurora Investigative Center

    Porto Alegre, Brazil

  • Aurora Investigative Center

    Salvador, Brazil

  • Aurora Investigative Center

    São Paulo, Brazil

Bulgaria
  • Aurora Investigative Center

    Plovdiv, Bulgaria

  • Aurora Investigative Center

    Smolyan, Bulgaria

  • Aurora Investigative Center

    Sofia, Bulgaria

  • Aurora Investigative Center

    Stara Zagora, Bulgaria

  • Aurora Investigative Center

    Vidin, Bulgaria

Canada
  • Aurora Investigative Center

    Edmonton, Alberta, Canada

  • Aurora Investigative Center

    Montreal, Quebec, Canada

  • Aurora Investigative Center

    Toronto, Canada

Chile
  • Aurora Investigative Center

    Santiago, Chile

  • Aurora Investigative Center

    Temuco, Chile

  • Aurora Investigative Center

    Valdivia, Chile

Colombia
  • Aurora Investigative Center

    Barranquilla, Colombia

  • Aurora Investigative Center

    Bogotá, Colombia

  • Aurora Investigative Center

    Bucaramanga, Colombia

  • Aurora Investigative Center

    Zipaquirá, Colombia

Costa Rica
  • Aurora Investigative Center

    San José, Costa Rica

  • Aurora Investigative Center

    San José, Costa Rica

Croatia
  • Aurora Investigative Center

    Osijek, Croatia

  • Aurora Investigative Center

    Zagreb, Croatia

Dominican Republic
  • Aurora Investigative Center

    Santiago de los Caballeros, Dominican Republic

  • Aurora Investigative Center

    Santo Domingo, Dominican Republic

Guatemala
  • Aurora Investigative Center

    Guatemala City, Guatemala

Japan
  • Aurora Investigative Center

    Kita, Osaka, Japan

  • Aurora Investigative Center

    Chiba, Japan

  • Aurora Investigative Center

    Hiroshima, Japan

  • Aurora Investigative Center

    Ishikawa, Japan

  • Aurora Investigative Center

    Kita-ku, Japan

  • Aurora Investigative Center

    Kitakyushu, Japan

145 more sites on the registry record.ClinicalTrials.gov ↗

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
17 May 2017
Primary completion
24 Sept 2019
Completion
10 Oct 2019
Last update posted
27 Mar 2023
Registered enrollment
358
Registry id
NCT03021499

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.